General |
Canadian Cancer Trials Group CO.21 Trial Newsletter |
The May 2009 edition of the Canadian Cancer Trials Group CO.21 Trial Newsletter is now available. To view the newsletter, please follow this link ... http://www.ctg.queensu.ca/trials/gastro-intestinal/co21/newsletters/CO21-PACNewsletterMAY2009.pdf
Also, congratulations to the Cancer Centre of Southeastern Ontario in Kingston for enrolling the study's first participant! Canadian Cancer Trials Group CO.21 is a Phase III randomized controlled study of the impact of a physical activity program on disease-free survival in patients with high risk stage II or stage III colon cancer. For complete information about CO.21, please visit the trial website at http://www.ctg.queensu.ca/trials/gastro-intestinal/co21/co21.html. |